Erratum: Bone morphogenetic protein 4 ameliorates bleomycin-induced pulmonary fibrosis in mice by repressing NLRP3 inflammasome activation and epithelial-mesenchymal transition
Erratum to: J Thorac Dis 2024;16:4875-91.
In the published article entitled “Bone morphogenetic protein 4 ameliorates bleomycin-induced pulmonary fibrosis in mice by repressing NLRP3 inflammasome activation and epithelial-mesenchymal transition” (1), there’s an error in the immunofluorescence image of Caspase-1 in BMP4 group of Figure 5A. The mistake was due to an unconscious label error at the time of taking the immunofluorescence image.
The original Figure 5A is presented below:
In order to revalidate the accuracy of this data, the authors repeated the whole experiment of Caspase-1 immunofluorescence staining in Figure 5A. The correct version of Figure 5A is shown below.
The authors regretted the errors and confirmed they will not change the results or conclusions of the article.
Click here to view the updated version of the article.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- Xu X, Yuan L, Hu X, et al. Bone morphogenetic protein 4 ameliorates bleomycin-induced pulmonary fibrosis in mice by repressing NLRP3 inflammasome activation and epithelial-mesenchymal transition. J Thorac Dis 2024;16:4875-91. [Crossref] [PubMed]
